Solid Lipid Nanoparticles for Enhancing the Bioavailability of Poorly Soluble Drugs

XU Na,ZHONG Wen-ying,ZHU Dan-ni

DOI: https://doi.org/10.3969/j.issn.1673-7717.2007.08.029

2007-01-01

Abstract:Solid lipid nanoparticles is a new drug delivery system, which can enhance the bioavailability of poorly soluble drugs.This paper reviews the mechanism and application of SLN for enhancing the bioavailability of poorly soluble drugs.

What problem does this paper attempt to address?

Solid Lipid Nanoparticles as Drug Delivery System

Li Xinwei,Sun Lixin,Lin Xiaohong,Zheng Liqiang

DOI: https://doi.org/10.3321/j.issn:1005-281X.2007.01.010

2007-01-01

Progress in chemistry

Abstract:Solid lipid nanoparticle is a new drug delivery system of nano-range. This paper reviews research development of solid lipid nanoparticle as drug carrier, including its components, preparation and surfacial modification, as well as its physico-chemical characteristics, drug incorporation and drug release.
Solid lipid nanoparticles; as a promising drug delivery method to get greater bioavailability: A review

Manisha A. Lavate,Sujit T. Karpe,Sidaray N. Biradar,Madanna R. Bhandare

DOI: https://doi.org/10.30574/wjbphs.2023.14.2.0104

2023-05-30

World Journal of Biology Pharmacy and Health Sciences

Abstract:Solid lipid nanoparticles (SLN) are the heart of nanotechnology's tremendous development, with multiple practical benefits in drug delivery and research. Because of their size-dependent properties, solid Lipid nanoparticles can be used to create innovative medicines. Drug conversion into nanoparticles provides a new drug delivery concept that could be used for drug targeting. As a result, solid lipid nanoparticles have great promise reaching the goal of targeted and site-specific drug delivery. The goals, production techniques, advantages, limits are all discussed in this review. Scanning electron microscopy and measurement of particle size and zeta potential, dynamic light scattering are examples of appropriate analytical techniques for SLN characterization. By using novel drug formulation technologies, the drug delivery system focuses on the regulation of in vivo dynamics in order to enhance the efficacy and safety of the included pharmaceuticals. Lipids used in the development of Nano particulate dosage forms, such as fatty acids, triglycerides, vegetable oils, and their derivatives. Solid lipid nanoparticles (SLNs) are a type of lipid drug delivery method that is relatively new. They were created to solve some of the limitations with traditional drug delivery systems, such as low drug encapsulation efficiency and limited bioavailability of Biopharmaceutical Classification Systems (BCS) class II and IV medications. SLNs are made up of physiologically well tolerated substances and melt-emulsified lipids that are solid at room temperature that helps to enhance drug bioavailability ultimately results in better desired therapeutic effect.
Lipid nanoparticles for enhancing oral bioavailability

Anushareddy Gangavarapu,Lillian V Tapia-Lopez,Barnali Sarkar,Jaqueline Pena-Zacarias,Abu Zayed Md Badruddoza,Md Nurunnabi

DOI: https://doi.org/10.1039/d4nr01487a

IF: 6.7

2024-10-10

Nanoscale

Abstract:In recent studies, lipid nanoparticles have attracted attention as drug delivery systems owing to their preeminent potential in achieving the desired bioavailability of biopharmaceutics (BCS) class II and class IV drugs. The current debate concerns the bioavailability of these poorly absorbed drugs with their simultaneous oral degradation. Lipid nanoparticles, including solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), are lipid-based carrier systems that can effectively encapsulate both lipophilic and hydrophilic drugs, offering versatile drug delivery systems. The unique properties of lipids (biodegradability and biocompatibility) and their transportation pathways enhance the biological availability of drugs. These particles can increase the gastrointestinal absorption and solubilization of minimally bioavailable drugs via a selective lymphatic pathway. This review mainly focuses on providing a brief update on lipid nanoparticles (LNPs) that synergistically increase the bioavailability of limited permeable drugs and highlight the transversal mechanisms of LNPs across the gastrointestinal hurdles, transmembrane absorption, transport kinetics, and computational tools. Finally, the present hurdles and future perspectives of LNPs for oral drug delivery systems are discussed.
Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs).

Jing Wang,Jing Chen,Niansong Ye,Zhiqiang Luo,Wenli Lai,Xiaoxiao Cai,Yunfeng Lin

DOI: https://doi.org/10.2174/138920012800166553

2012-01-01

Current Drug Metabolism

Abstract:In recent years, many researchers have paid more and more attentions on the use of Nanotechnology. Solid lipid nanoparticles (SLNs) are emerged as a promising alternation herein to emulsions, liposomes, microparticles and polymeric nanoparticles for their advantages. As promising drug carrier systems, SLNs are valuable for nanomedicine and have been widely used as delivery systems mostly for drugs and macromolecules like proteins, oligonucleotides and DNA by various application routes, such as intravenous, oral, duodenalous, intramuscular, pulmonary, intranasal, ocular, rectal and intraperitoneal administrations. It has been shown that SLNs can increase bioavailability, alter pharmacokinetic parameters and tissue distribution of the drug loaded. In this review, we will primarily focus on the absorption, pharmacokinetics and disposition properties of SLNs for their possible applications in drug delivery.
Study and Application of Solid Lipid Nanoparticles

刘春喜,张娜

DOI: https://doi.org/10.3969/j.issn.1672-979x.2009.04.019

2009-01-01

Abstract:Solid lipid nanoparticles(SLN) have attracted increasing attention as an efficient and non-toxic alternative lipophilic colloidal drug carrier in recent years.In this article,the research and application of SLN are reviewed in gene delivery,non-injection system for protein and polypeptide,solubilization and targeted drug delivery system on the basics of owr work and relative documents.
Solid Lipid Nanoparticles For Enhanced Oral Absorption: A Review

Eman Salah,Mahmoud M. Abouelfetouh,Yuanhu Pan,Dongmei Chen,Shuyu Xie

DOI: https://doi.org/10.1016/j.colsurfb.2020.111305

2020-01-01

Abstract:Recent trends in nanoparticles-based oral therapy have led to a proliferation of studies to enhance solubility, permeability and chemical stability of many drugs. One of the significant current discussions is achieving high bioavailability of drugs poorly absorbed with an impairing coincidence of oral degradation. Solid lipid nanoparticles (SLNs), absorbed and trafficked via transcellular and paracellular pathways, are one of the utmost innovative promising nanocarriers to overwhelm drawbacks of the poorly absorbed drugs. The central topic of this review is focusing on providing brief updates on SLNs for improving drug oral absorption with their evolutions in curing numerous ailments. In order to create a new paradigm of therapeutic formulations, we also highlight the transversal mechanisms of SLNs across the gastrointestinal hurdles and a series of novel researches regarding in vitro protocols to uncover the investigations of the transmembrane absorption and transport kinetics of SLNs. The current challenges and future perspectives of SLNs for oral drug delivery are refined and forecasted. Several questions remain unanswered and it is recommended to pay a close attention to the most sophisticated in vivo-like culture practices which open new avenues to thoroughly elucidate how SLNs interact with intestinal mucosa at cellular and molecular levels. Additionally, further studies are needed to concentrate on the factors influencing the absorption efficiency, proportion of SLNs in gastrointestinal tract as well as their correlation with their loaded drug bioavailability.
Solid Lipid Nanoparticles: Drug Delivery Systems for Enhancing the Bioavailability of Antihypertensives

Neeraj K. Chauhan,Anuj Malik,Paramjeet K. Ratiyen

DOI: https://doi.org/10.25258/ijddt.13.3.46

2023-09-25

International Journal of Drug Delivery Technology

Abstract:The pharmaceutical industry focuses the SLNs as promising drug deliverance methods for improving bioavailability. SLNs are a swiftly budding field of nanotechnology amid plentiful budding applications in medicine and research. Lipid-based nanoparticles possess unique properties due to their small size, allowing novel therapeutics to be developed. The encapsulation of drugs within nano-carriers presents a new paradigm in drug delivery, enabling enhanced targeting at secondary and tertiary levels. Consequently, SLNs have garnered significant attention from researchers for their site-specific drug delivery. This review enlightens on the responsibilities of SLN for improving the pharmacokinetics of poorly soluble antihypertensive drugs. Profound investigations confirmed SLNs have latent to transfigure antihypertensives through enhanced oral delivery.
Application of lipid-based nanocarriers for poorly soluble drug delivery

ZHANG Juan,ZHANG Na

2012-01-01

Abstract:With the widespread application of new technology in drug discovery,an increasing number of active drug candidates have been developed.However,many of them are difficult to enter the formulation development stage due to their poor water solubility.Recently,the use of nanoparticulate carriers has drawn more and more attention.This paper reviewed the application of various lipid-based nanocarriers for poorly soluble drugs delivery,including microemulsions,fat emulsions,liposomes,solid lipid nanoparticles, nanostructured lipid carriers,lipid-based-nanosuspensions and biomimetic carriers,in order to provide some new strategies for product development.
Solid Lipid Nanoparticles (SLNs): Advancements in Modification Strategies Toward Drug Delivery Vehicle

Galal Mohsen Hussein Al-Sayadi,Abhishek Verma,Yash Choudhary,Pallavi Sandal,Preeti Patel,Dilpreet Singh,Ghanshyam Das Gupta,Balak Das Kurmi

DOI: https://doi.org/10.2174/2211738511666221026163303

Abstract:Solid lipid nanoparticles are at the cornerstone of the swiftly growing area of medical nanotechnology, having several potential functions in drug delivery, research, clinical care, and a variety of other fields. They provide the opportunity of developing novel therapies due to their unique properties, such as small particle size and being prepared from physiological biodegradable lipids. The loading of bioactive molecules into nanocarriers is a novel drug delivery prototype employed for various drug targeting levels. Hence, SLNs hold a great promise for achieving the aim of targeted and controlled drug delivery. For this reason, they have attracted the extensive attention of scientists and researchers. This review is based on recent studies and research, and here we present advantages, disadvantages, and preparation methods, several advanced modifications, targeting strategies, and recent applications of solid lipid nanocarriers in drug delivery systems.
Solid lipid nanocarriers as alternative drug delivery system for improved oral delivery of drugs

A. Ramesh,G. Thirupathi,Samanthula Kumara Swamy

DOI: https://doi.org/10.22270/JDDT.V10I6-S.4410

2020-12-15

Journal of Drug Delivery and Therapeutics

Abstract:Oral bioavailability of drugs is mainly limited due to the poor aqueous solubility, enhanced chemical degradation, reduced permeation and/or first pass metabolism. Various novel delivery systems are developed for improved oral bioavailability of these drugs such as modified orals, buccal, transdermal and osmotic delivery systems. Colloidal carrier systems such as nanoparticles, lipid nanoparticles, nanoemulsions, microspheres, liposomes, resealed erythrocytes and transfersomes were also developed to enhance the oral delivery. Among these, solid lipid nanocarriers (SLNs) also gain much attention on the enhancement of oral bioavailability. SLNs are submicron sized nanoparticles and composed of solid lipid, surfactants and cosurfactants. The enhanced oral bioavailability of poorly soluble drugs from SLNs might be due to the reduced particle size, bypassed presystemic metabolism, and enhanced gastric mucosa permeability. Vast literature is available for the advantages, limitations, preparation methods, evaluation parameters and application of SLNs in different routes. This review mainly focused on list of drugs developed as SLNs and considered as an alternative approach to enhance the oral bioavailability based on pharmacokinetic as well as pharmacodyanmic parameters was discussed. Keywords: Oral bioavailability, solubility, first-pass metabolism, solid lipid nanoparticles, pharmacokinetics, pharmacodynamics.

Chemistry,Medicine,Materials Science
Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery

M C Teixeira,C Carbone,E B Souto

DOI: https://doi.org/10.1016/j.plipres.2017.07.001

Abstract:Solid lipid nanoparticle (SLN), nanostructured lipid carriers (NLC) and hybrid nanoparticles, have gained increasing interest as drug delivery systems because of their potential to load and release drugs from the Biopharmaceutical classification system (BCS) of class II (low solubility and high permeability) and of class IV (low solubility and low permeability). Lipid properties (e.g. high solubilizing potential, biocompatibility, biotolerability, biodegradability and distinct route of absorption) contribute for the improvement of the bioavailability of these drugs for a set of administration routes. Their interest continues to grow, as translated by the number of patents being field worldwide. This paper discusses the recent advances on the use of SLN, NLC and lipid-polymer hybrid nanoparticles for the loading of lipophilic, poorly water-soluble and poorly permeable drugs, being developed for oral, topical, parenteral and ocular administration, also discussing the industrial applications of these systems. A review of the patents filled between 2014 and 2017, concerning the original inventions of lipid nanocarriers, is also provided.
Application of Lipid Nanoparticles As Oral Drug Delivery System

Qi Jian-Ping,Lu Yi,Wu Wei

DOI: https://doi.org/10.3724/sp.j.1206.2013.00282

2013-01-01

Abstract:Lipid nanoparticles are prepared with solid fatty acids or esters, which is widely concerned in drug delivery due to their good biocompatiblity and safety. The oral bioavailability of poor-soluble drugs, peptides and proteins are very low because of their poor solubility, permeability or stability. However, lipid nanoparticles as their carrier can improve the oral bioavailability significantly, which enhance the application or investigation of lipid nanoparticles as oral drug delivery systems. This paper reviews the four aspects of lipid nanoparticles, including formualtion, preparation, absorption mechanism and application in oral delivery.
Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.

Jianping Qi,Yi Lu,Wei Wu

DOI: https://doi.org/10.2174/138920012800166526

2012-01-01

Current Drug Metabolism

Abstract:Solid lipid nanoparticles (SLNs) are primarily composed of solid lipids, which thus impart to them some of the fundamental properties of these lipids, including biocompatibility, biodegradability and low-toxicity. SLNs represent a unique class of colloidal drug delivery systems that possess the advantages of both the "soft" drug carriers such as emulsions and liposomes and polymeric nanoparticles. In this review, we will provide an overview on the absorption, disposition and pharmacokinetics of SLNs. The lipidic nature, as well as the relatively small particle size, of SLNs ensures sufficient affinity with the biomembranes, and results in improved absorption by either of the oral, transdermal, pulmonary, nasal, ocular, rectal or buccal route. One special aspect of oral SLNs is the enhanced lymphatic absorption by either the chylomicron-association pathway or the M cell uptaking pathway. Intravenous SLNs are predominantly uptaken by the liver or spleen following opsonization by the complementary system. Modification of SLN surface with PEGs chains will mask the hydrophobic surface and divert SLNs to non-hepatic and non-splenic organs, while ligand-modification will achieve active targeting to specific tissues or organs. Degradation of SLNs is primarily based on the degradation of the lipids themselves by lipase. Pharmacokinetics reflects the effect of the lipidic vehicles of SLNs on in vivo disposition of the loaded drugs.
The Science of Solid Lipid Nanoparticles: From Fundamentals to Applications

Navaneetha Krishnan M,Sangeetha S,Sree Ranjani P,Damodharan Narayanasamy

DOI: https://doi.org/10.7759/cureus.68807

2024-09-06

Cureus

Abstract:Solid lipid nanoparticles (SLNs) play a crucial role in drug delivery, offering benefits such as enhanced bioavailability, targeted distribution, and reduced toxicity. This article provides a comprehensive overview of SLN formulation, development, and advancement in pharmaceutical research, examining their characteristics, classifications, and significance. The review also delves into the real-world applicability of various SLN formulations across different routes of administration, discussing their advantages, disadvantages, and challenges of scalability, along with strategies for efficient implementation. Furthermore, it explores the diverse applications of SLNs through various delivery methods, addressing the obstacles and potential solutions. By highlighting the critical role of SLNs in improving treatment outcomes, this review underscores their importance in modern drug delivery systems.
Solid Lipid Nanoparticles: A Review of their Biomedical Applications and Preparation

Mayukh Jana,Ujjwal Kumar Biswas,Chandra Sekhar Patra,Biplab Debnath,Suraj Sharma,Sweet Naskar

DOI: https://doi.org/10.2174/0122117385312175240502100018

2024-05-23

Abstract:Solid lipid nanoparticles (SLNs) are gaining significant attention in the pharmaceutical industry due to their biocompatibility and biodegradability, making them a popular functional nanocarrier. SLNs are a popular nanocarrier due to their ability to bypass the spleen and liver, offer high drug stability, and improve bioavailability, sterilization, immobilization, targeted drug release, and biocompatible ingredients. This article discusses various SLN preparation techniques, including high shear homogenization, hot homogenization, cold homogenization, microemulsion-based, solvent evaporation, solvent emulsification-evaporation, supercritical fluid-based, spray drying, double emulsion, and precipitation techniques, focusing on methodological aspects. This review discusses the physicochemical behavior of SLNs, including drug loading, release, particle size, stability, cytotoxicity, and cellular uptake, and their major biomedical applications.
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Emerging Lipid Based Drug Delivery Systems

Rupesh K. Shirodkar,Lalit Kumar,Srinivas Mutalik,Shaila Lewis

DOI: https://doi.org/10.1007/s11094-019-02017-9

2019-08-01

Pharmaceutical Chemistry Journal

Abstract:In the past decade, research in the area of nanodrug delivery has reached a new height with the advent of lipid based nanodrug delivery systems. Lipids being biocompatible and possessing diverse physicochemical properties have tremendous potential to enhance oral bioavailability of water insoluble drugs. Incorporation of a drug in lipid carriers is a smart approach to overcome problems related with conventional oral therapy. In recent years, two lipid based nanoparticles, namely solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) are widely explored. SLN are spherical nanoparticles with a drug-containing solid lipid core stabilized with surfactants and formulated mainly to improve bioavailability of the drug molecules. Despite several advantages of SLNs, their major drawbacks include limited drug loading, drug leakage, and crystallization during storage. These drawbacks were avoided or reduced by the development of a new generation of lipid nanoparticles, the NLC, wherein a solid lipid is blended with liquid lipid. Modulation of drug release was added advantage with NLC formulations. The present review focuses on production techniques, characterization, release characteristics, stability, toxicity and potential applications of SLNs and NLCs.

pharmacology & pharmacy,chemistry, medicinal
Research and Development of Solid Lipid Nanoparticles

Shilong Wang

2005-01-01

Abstract:OBJECTIVE To review the latest research development of the solid lipid nanoparticles(SLN). METHODS According to the recent relevant literature, the preparations for the SLN, characterization analysis, drug incorporation, drug release, and its application in the pharmaceutical field were summarized. Its development prospect and unsolved problem were pointed out .RESULTS Each preparations of the SLN has advantages and disadvantages.The drug incorporation and release profiles could be modified as adjustment of production parameters.CONCLUSION The SLN could be used by various administration,and they have broad prospects in the pharmaceutical field.
Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages

Parisa Ghasemiyeh,Soliman Mohammadi-Samani

DOI: https://doi.org/10.4103/1735-5362.235156

2018-01-01

Research in Pharmaceutical Sciences

Abstract:During the recent years, more attentions have been focused on lipid base drug delivery system to overcome some limitations of conventional formulations. Among these delivery systems solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) are promising delivery systems due to the ease of manufacturing processes, scale up capability, biocompatibility, and also biodegradability of formulation constituents and many other advantages which could be related to specific route of administration or nature of the materials are to be loaded to these delivery systems. The aim of this article is to review the advantages and limitations of these delivery systems based on the route of administration and to emphasis the effectiveness of such formulations.
Recent Advances in the Preparation, Properties, and Applications of Solid Lipid Nanoparticles in Drug Delivery

Ujjwal Kumar Biswas,Anindya Bose,Ankita Parmanik

DOI: https://doi.org/10.2174/0122117385333634240911075833

2024-09-19

Abstract:Solid lipid nanoparticles (SLNs) are one of the extensively utilized nanocarriers in the pharmaceutical field due to their biocompatibility and biodegradability. These features of the carrier system have fuelled its use as the drug delivery system since the last three decades. This review presents different SLN preparation techniques, such as high shear homogenization, hot homogenization, cold homogenization, microemulsion-based technique, etc. The physicochemical nature of SLNs, comprising drug loading, drug release, particle size, zeta potential, stability, cytotoxicity, and cellular uptake, has been concisely discussed. The article also explains why SLNs are preferred to develop drug delivery systems in several pharmaceutical preparations. The key ingredients like lipid, surfactant/ stabilizer accompanied by co-surfactant, cryoprotectant, or charge modifiers used to fabricate SLNs are also briefly conferred. Here is an elaborate discussion of drugs that are used through various routes by the SLN carrier system and their outcome for utilization of this system. Regulatory aspects, patent aspects, and future prospects of SLN are also discussed here.
New Developments in Solid Lipid Nanoparticles

陈玲,周建平

DOI: https://doi.org/10.3969/j.issn.1001-5094.2003.06.008

2003-01-01

Abstract:The preparation method, application, existing problems and their solutions and the prospect of solid lipid nanoparticles were reviewed. Novel carriers based on SLN, nanostructured lipid carriers and lipid drug conjucates were briefly introduced.

Solid Lipid Nanoparticles for Enhancing the Bioavailability of Poorly Soluble Drugs

Solid Lipid Nanoparticles as Drug Delivery System

Solid lipid nanoparticles; as a promising drug delivery method to get greater bioavailability: A review

Lipid nanoparticles for enhancing oral bioavailability

Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs).

Study and Application of Solid Lipid Nanoparticles

Solid Lipid Nanoparticles For Enhanced Oral Absorption: A Review

Solid Lipid Nanoparticles: Drug Delivery Systems for Enhancing the Bioavailability of Antihypertensives

Application of lipid-based nanocarriers for poorly soluble drug delivery

Solid Lipid Nanoparticles (SLNs): Advancements in Modification Strategies Toward Drug Delivery Vehicle

Solid lipid nanocarriers as alternative drug delivery system for improved oral delivery of drugs

Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery

Application of Lipid Nanoparticles As Oral Drug Delivery System

Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.

The Science of Solid Lipid Nanoparticles: From Fundamentals to Applications

Solid Lipid Nanoparticles: A Review of their Biomedical Applications and Preparation

Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Emerging Lipid Based Drug Delivery Systems

Research and Development of Solid Lipid Nanoparticles

Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages

Recent Advances in the Preparation, Properties, and Applications of Solid Lipid Nanoparticles in Drug Delivery

New Developments in Solid Lipid Nanoparticles